Compare XAIR & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XAIR | OXBR |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | 4 |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.1M |
| IPO Year | 2015 | N/A |
| Metric | XAIR | OXBR |
|---|---|---|
| Price | $0.50 | $0.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $5.00 |
| AVG Volume (30 Days) | 336.8K | ★ 1.3M |
| Earning Date | 06-16-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,705,000.00 | N/A |
| Revenue This Year | $122.00 | $80.09 |
| Revenue Next Year | $58.15 | $85.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 219.67 | N/A |
| 52 Week Low | $0.15 | $0.66 |
| 52 Week High | $3.78 | $2.85 |
| Indicator | XAIR | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 35.74 | 55.49 |
| Support Level | $0.43 | $0.76 |
| Resistance Level | $0.82 | $0.95 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 17.29 | 93.54 |
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.